These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18693059)

  • 41. Exposure assessment as a component of observational health studies and environmental risk assessment.
    Ott MG
    Scand J Work Environ Health; 2005; 31 Suppl 1():110-4; discussion 63-5. PubMed ID: 16190157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Rodriguez C; Jacobs EJ; Deka A; Patel AV; Bain EB; Thun MJ; Calle EE
    Cancer Causes Control; 2009 Jul; 20(5):671-9. PubMed ID: 19067188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003.
    Golden R; Kimbrough R
    Crit Rev Toxicol; 2009; 39(4):299-331. PubMed ID: 19514916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of non-selective non-steroidal anti-inflammatory drugs on the aggressiveness of prostate cancer.
    Stock DC; Groome PA; Siemens DR; Rohland SL; Song Z
    Prostate; 2008 Nov; 68(15):1655-65. PubMed ID: 18698582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health risk evaluation for the inhabitants of a typical mining town in a mountain area, South China.
    Zhang XY; Tang XL; Zhao CL; Zhang G; Hu HS; Wu HD; Hu B; Mo LP; Huang L; Wei JG
    Ann N Y Acad Sci; 2008 Oct; 1140():263-73. PubMed ID: 18991924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy.
    Antonelli JA; Jones LW; Bañez LL; Thomas JA; Anderson K; Taylor LA; Gerber L; Anderson T; Hoyo C; Grant D; Freedland SJ
    J Urol; 2009 Nov; 182(5):2226-31. PubMed ID: 19758620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of European legislation on marketed pesticides--a view from the standpoint of health impact assessment studies.
    Karabelas AJ; Plakas KV; Solomou ES; Drossou V; Sarigiannis DA
    Environ Int; 2009 Oct; 35(7):1096-107. PubMed ID: 19632722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of pesticide exposure on the human immune system.
    Corsini E; Liesivuori J; Vergieva T; Van Loveren H; Colosio C
    Hum Exp Toxicol; 2008 Sep; 27(9):671-80. PubMed ID: 19042949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer.
    Mononen N; Schleutker J
    J Urol; 2009 Apr; 181(4):1541-9. PubMed ID: 19230916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antidiabetic medication and prostate cancer risk: a population-based case-control study.
    Murtola TJ; Tammela TL; Lahtela J; Auvinen A
    Am J Epidemiol; 2008 Oct; 168(8):925-31. PubMed ID: 18700234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate cancer and vasectomy: a hospital-based case-control study in China, Nepal and the Republic of Korea.
    Schwingl PJ; Meirik O; Kapp N; Farley TM;
    Contraception; 2009 May; 79(5):363-8. PubMed ID: 19341848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring and reducing exposure of infants to pollutants in house dust.
    Roberts JW; Wallace LA; Camann DE; Dickey P; Gilbert SG; Lewis RG; Takaro TK
    Rev Environ Contam Toxicol; 2009; 201():1-39. PubMed ID: 19484587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Premature thelarche and environmental pollutants.
    Chiabotto P; Costante L; de Sanctis C
    Minerva Med; 2006 Jun; 97(3):277-85. PubMed ID: 16855522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
    Shaik AP; Jamil K; Das P
    Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic renal failure in North Central Province of Sri Lanka: an environmentally induced disease.
    Wanigasuriya KP; Peiris-John RJ; Wickremasinghe R; Hittarage A
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):1013-7. PubMed ID: 17643458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining increased future risk for prostate cancer: evidence from a population based screening cohort.
    Schröder FH; Roobol MJ; Andriole GL; Fleshner N
    J Urol; 2009 Jan; 181(1):69-74; discussion 74. PubMed ID: 19012915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Environmental pollutants in maternal milk and cryptorchidism].
    Brucker-Davis F; Ducot B; Wagner-Mahler K; Tommasi C; Ferrari P; Pacini P; Boda-Buccino M; Bongain A; Azuar P; Fénichel P
    Gynecol Obstet Fertil; 2008 Sep; 36(9):840-7. PubMed ID: 18707911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Susceptibility to cancer: some examples from epidemiology.
    Jensen OM
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):399-404. PubMed ID: 6100142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.